DiaResQ gives physicians an option for a highly effective nature-based treatment of diarrhoea.
Pakistan based Ferozsons Laboratories Ltd. has partnered with PanTheryx Inc., a US life science company, to launch DiaResQ sachets, a breakthrough nutritional innovation for diarrhoea relief in children and adults.
DiaResQ gives physicians an option for a highly effective nature-based treatment of diarrhoea, a disease that annually claims the lives of over 125,000 children under the age of 5 in Pakistan alone.
DiaResQ supplements use of oral rehydration solution and zinc by providing nutrients for intestinal repair. Most children that suffer from diarrhoea in Pakistan are also reported to be malnourished.
According to a study published by the British Medical Journal (BMJ), DiaResQ has demonstrated efficiency in treating acute childhood diarrhoea caused by the most common pathogens. Ninety-six percent (96%) of the diarrhoea cases were resolved with a single dose of DiaResQ taken for three days – it significantly reduced fifty-six percent (56%) diarrhoea episodes on day 1 of treatment.
